Although research on the neural substrates and pharmacokinetics of the anxiolytic-like effects of ST4070 in rodents is still needed, the present investigation opens new avenues to the development and further evaluation of a new family of FAAH inhibitors as drugs to be tested in clinical trials for the management of anxiety and mood disorders in humans. The gene discussed is FAAH; the disease is Anxiety.